311 related articles for article (PubMed ID: 32067281)
21. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K
Eur J Neurol; 2021 Dec; 28(12):4153-4166. PubMed ID: 34487400
[TBL] [Abstract][Full Text] [Related]
22. Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.
Magon S; Tsagkas C; Gaetano L; Patel R; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Stippich C; Kappos L; Chakravarty MM; Sprenger T
J Neurol; 2020 May; 267(5):1536-1546. PubMed ID: 32040710
[TBL] [Abstract][Full Text] [Related]
23. Cervical cord lesion load is associated with disability independently from atrophy in MS.
Kearney H; Altmann DR; Samson RS; Yiannakas MC; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
Neurology; 2015 Jan; 84(4):367-73. PubMed ID: 25540312
[TBL] [Abstract][Full Text] [Related]
24. Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis.
Sestito C; Leurs CE; Steenwijk MD; Brevé JJP; Twisk JWR; Wilhelmus MMM; Drukarch B; Teunissen CE; van Dam AM; Killestein J
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 33906937
[TBL] [Abstract][Full Text] [Related]
25. In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.
Choi IY; Lee P; Adany P; Hughes AJ; Belliston S; Denney DR; Lynch SG
Mult Scler; 2018 Jul; 24(8):1029-1038. PubMed ID: 28569645
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI.
Treaba CA; Granberg TE; Sormani MP; Herranz E; Ouellette RA; Louapre C; Sloane JA; Kinkel RP; Mainero C
Radiology; 2019 Jun; 291(3):740-749. PubMed ID: 30964421
[TBL] [Abstract][Full Text] [Related]
27. Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis.
Conte A; Lenzi D; Frasca V; Gilio F; Giacomelli E; Gabriele M; Bettolo CM; Iacovelli E; Pantano P; Pozzilli C; Inghilleri M
J Neurol; 2009 Jun; 256(6):933-8. PubMed ID: 19252788
[TBL] [Abstract][Full Text] [Related]
28. Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study.
Calabrese M; Grossi P; Favaretto A; Romualdi C; Atzori M; Rinaldi F; Perini P; Saladini M; Gallo P
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):49-54. PubMed ID: 21890577
[TBL] [Abstract][Full Text] [Related]
29. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status.
Masek M; Vaneckova M; Krasensky J; Danes J; Havrdova E; Hrebikova T; Seidl Z
Neuro Endocrinol Lett; 2008 Aug; 29(4):461-6. PubMed ID: 18766142
[TBL] [Abstract][Full Text] [Related]
30. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Barkhof F; Schoonheim MM; Strijbis EM; Vrenken H; Gallo A; Bisecco A; Ciccarelli O; Yiannakas M; Rovira A; Sastre-Garriga J; Palace J; Matthews L; Gass A; Eisele P; Lukas C; Bellenberg B; Margoni M; Preziosa P; Filippi M;
J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
[TBL] [Abstract][Full Text] [Related]
31. Structural and cognitive correlates of fatigue in progressive multiple sclerosis.
Andreasen AK; Iversen P; Marstrand L; Siersma V; Siebner HR; Sellebjerg F
Neurol Res; 2019 Feb; 41(2):168-176. PubMed ID: 30513278
[TBL] [Abstract][Full Text] [Related]
32. Cortical atrophy is relevant in multiple sclerosis at clinical onset.
Calabrese M; Atzori M; Bernardi V; Morra A; Romualdi C; Rinaldi L; McAuliffe MJ; Barachino L; Perini P; Fischl B; Battistin L; Gallo P
J Neurol; 2007 Sep; 254(9):1212-20. PubMed ID: 17361339
[TBL] [Abstract][Full Text] [Related]
33. Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
Haider L; Prados F; Chung K; Goodkin O; Kanber B; Sudre C; Yiannakas M; Samson RS; Mangesius S; Thompson AJ; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Chard DT; Barkhof F
Brain; 2021 Jun; 144(5):1384-1395. PubMed ID: 33880511
[TBL] [Abstract][Full Text] [Related]
34. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
[TBL] [Abstract][Full Text] [Related]
35. Patterns of cortical grey matter thickness reduction in multiple sclerosis.
Fujimori J; Fujihara K; Wattjes M; Nakashima I
Brain Behav; 2021 Apr; 11(4):e02050. PubMed ID: 33506628
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT
Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608
[TBL] [Abstract][Full Text] [Related]
37. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
[TBL] [Abstract][Full Text] [Related]
38. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
39. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
Galego O; Gouveia A; Batista S; Moura C; Machado E
Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
[TBL] [Abstract][Full Text] [Related]
40. T2 lesions and rate of progression of disability in multiple sclerosis.
Mostert JP; Koch MW; Steen C; Heersema DJ; De Groot JC; De Keyser J
Eur J Neurol; 2010 Dec; 17(12):1471-5. PubMed ID: 20500805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]